Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery : Subgroup Analysis From the TRACER Trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David Whellan, Pierluigi Tricoci, Edmond Chen, Zhen Huang, David Leibowitz, Pascal Vranckx, Gregary Marhefka, Claes Held, J Nicolau, Robert Storey, Witold Ruzyllo, Kurt Huber, Peter Sinnaeve, A Weiss, Jean-Pierre Dery, David Moliterno, F Van De Werf, Philip Aylward, Harvey White, Paul ArmstrongLars Wallentin, John Strony, Robert Harrington, Kenneth Mahaffey
Research output: Contribution to journal › Article › peer-review
44Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery : Subgroup Analysis From the TRACER Trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)'. Together they form a unique fingerprint.